Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Translating genetic pathways to protein networks for cancer sub-typing.

Eltze E, Schmidt H, Semjonow A, Brandt B.

Ann Oncol. 2008 Jul;19 Suppl 5:v44-7. doi: 10.1093/annonc/mdn308. No abstract available.

PMID:
18611899
2.

Translation and cancer.

Topisirovic I, Sonenberg N.

Biochim Biophys Acta. 2015 Jul;1849(7):751-2. doi: 10.1016/j.bbagrm.2015.05.004. No abstract available.

PMID:
25988403
3.

Why do multiple deletions accumulate during progression in carcinomas?

Dutrillaux B.

Cancer Genet Cytogenet. 2001 Jul 1;128(1):48-9. No abstract available.

PMID:
11458950
4.

A fly with an ointment: Bcl-2 as an anti-mutator in tumors.

Gottlieb E.

Cancer Biol Ther. 2002 Jan-Feb;1(1):45-6. No abstract available.

PMID:
12197483
5.

Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activation.

Brodeur GM.

Prog Hematol. 1986;14:229-56. Review. No abstract available.

PMID:
3003796
6.

An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling.

Flach J, Dicker F, Schnittger S, Schindela S, Kohlmann A, Haferlach T, Kern W, Haferlach C.

Leukemia. 2011 Apr;25(4):713-8. doi: 10.1038/leu.2010.304. No abstract available.

PMID:
21233836
7.

Translation regulation as a therapeutic target in cancer.

Grzmil M, Hemmings BA.

Cancer Res. 2012 Aug 15;72(16):3891-900. doi: 10.1158/0008-5472.CAN-12-0026. Review.

8.

Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.

Speer R, Wulfkuhle J, Espina V, Aurajo R, Edmiston KH, Liotta LA, Petricoin EF 3rd.

Cancer Genomics Proteomics. 2007 May-Jun;4(3):157-64. Review.

9.

Immunohistochemistry 2015: Protein correlates of molecular alterations and predictive testing.

Hornick JL.

Semin Diagn Pathol. 2015 Sep;32(5):323-4. doi: 10.1053/j.semdp.2015.07.001. No abstract available.

PMID:
26250936
10.

Cyclin E and chromosome instability in colorectal cancer cell lines.

Simone C, Resta N, Bagella L, Giordano A, Guanti G.

Mol Pathol. 2002 Jun;55(3):200-3.

11.

Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.

Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C, Wang L, Zhao W, Jiang JD, Liu J.

Cancer Res. 2005 Sep 1;65(17):7635-43.

12.

FHIT in human cancer.

Sozzi G, Huebner K, Croce CM.

Adv Cancer Res. 1998;74:141-66. Review. No abstract available.

PMID:
9561268
13.

Protein glycosylation in cancer.

Stowell SR, Ju T, Cummings RD.

Annu Rev Pathol. 2015;10:473-510. doi: 10.1146/annurev-pathol-012414-040438. Review.

14.

Proceedings of the International Conference on Global mRNA and Protein Analysis. September 7-8, 2006. Dublin, Ireland.

[No authors listed]

Anticancer Res. 2007 May-Jun;27(3A):1237-385. No abstract available.

15.

Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.

Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM.

Neoplasia. 2007 Feb;9(2):166-80.

16.

Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors.

De Juan C, Iniesta P, González-Quevedo R, Morán A, Sánchez-Pernaute A, Torres AJ, Balibrea JL, Díaz-Rubio E, Cruces J, Benito M.

Oncogene. 2002 May 2;21(19):3089-94.

17.

Microdissection-based genetic discovery and analysis applied to cancer progression.

Dean-Clower E, Vortmeyer AO, Bonner RF, Emmert-Buck M, Zhuang Z, Liotta LA.

Cancer J Sci Am. 1997 Sep-Oct;3(5):259-65. Review. No abstract available.

PMID:
9327146
18.

Progression elevated gene-3, PEG-3, induces genomic instability in rodent and human tumor cells.

Su ZZ, Gopalkrishnan RV, Narayan G, Dent P, Fisher PB.

J Cell Physiol. 2002 Jul;192(1):34-44.

PMID:
12115734
19.

Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.

Mhawech P, Benz A, Cerato C, Greloz V, Assaly M, Desmond JC, Koeffler HP, Lodygin D, Hermeking H, Herrmann F, Schwaller J.

Mod Pathol. 2005 Mar;18(3):340-8.

20.

Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.

Woodman AC, Sugiyama M, Yoshida K, Sugino T, Borgya A, Goodison S, Matsumura Y, Tarin D.

Am J Pathol. 1996 Nov;149(5):1519-30.

Items per page

Supplemental Content

Support Center